National Health Investors (NYSE:NHI) Hits New 1-Year Low - What's Next?

Key Points

• National Health Investors shares fell to a new 52-week low, trading as low as $67.56 and down 2.4%, below both its 50-day and 200-day moving averages.
• Analyst sentiment remains mixed but leans positive: NHI has a consensus “Moderate Buy” rating and an average price target of $82.25, despite recent target cuts and one “strong sell” downgrade.
• The company announced a quarterly dividend of $0.92 per share, equating to a 5.4% annualized yield, while reporting quarterly revenue growth of 1.6% and providing fiscal 2026 EPS guidance of $4.74–$4.79.

National Health Investors, Inc. (NYSE:NHI - Get Free Report)'s stock price hit a new 52-week low during trading on Friday . The stock traded as low as $67.56 and last traded at $67.7880, with a volume of 92454 shares changing hands. The stock had previously closed at $69.23.

Analyst Ratings Changes

NHI has been the topic of several analyst reports. National Bank Financial set a $79.00 price target on shares of National Health Investors in a research report on Wednesday, September 9th. Truist Financial cut their target price on National Health Investors from $81.00 to $80.00 and set a "buy" rating for the company in a research note on Wednesday, September 2nd. Zacks Research downgraded National Health Investors from a "hold" rating to a "strong sell" rating in a report on Thursday, June 25th. Deutsche Bank Aktiengesellschaft decreased their price target on National Health Investors from $85.00 to $80.00 and set a "hold" rating on the stock in a research note on Thursday, June 25th. Finally, Weiss Ratings reissued a "buy (b-)" rating on shares of National Health Investors in a report on Wednesday, September 9th. Six analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, National Health Investors has a consensus rating of "Moderate Buy" and an average target price of $82.25.

National Health Investors Stock Down 2.4%

The company has a market capitalization of $3.32 billion, a P/E ratio of 19.55, a PEG ratio of 3.64 and a beta of 0.52. The company has a current ratio of 6.78, a quick ratio of 6.78 and a debt-to-equity ratio of 0.81. The stock has a 50 day moving average price of $74.16 and a 200 day moving average price of $76.96.

National Health Investors (NYSE:NHI - Get Free Report) last issued its quarterly earnings data on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share for the quarter. The business had revenue of $121.32 million for the quarter. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%.The company's revenue was up 1.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.22 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. On average, research analysts anticipate that National Health Investors, Inc. will post 4.76 earnings per share for the current fiscal year.

National Health Investors Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 6th. Investors of record on Wednesday, September 30th will be given a dividend of $0.92 per share. The ex-dividend date is Wednesday, September 30th. This represents a $3.68 annualized dividend and a yield of 5.4%. National Health Investors's dividend payout ratio (DPR) is currently 106.36%.

Institutional Investors Weigh In On National Health Investors

A number of institutional investors have recently added to or reduced their stakes in NHI. BlackRock Inc. bought a new stake in shares of National Health Investors in the 2nd quarter valued at about $665,997,000. Bank of New York Mellon Corp bought a new stake in National Health Investors in the second quarter valued at approximately $122,509,000. Bank of America Corp DE acquired a new stake in National Health Investors during the 2nd quarter valued at approximately $77,738,000. Norges Bank acquired a new stake in National Health Investors during the 4th quarter valued at approximately $55,301,000. Finally, Legal & General Group Plc bought a new position in National Health Investors during the 2nd quarter worth approximately $21,745,000. 62.51% of the stock is owned by institutional investors.

About National Health Investors

National Health Investors, Inc NYSE: NHI is a real estate investment trust that owns and finances healthcare real estate. The company focuses primarily on properties serving older adults and patients requiring specialized care, including independent living, assisted living, memory care, skilled nursing and continuing care retirement communities.

NHI generally leases its properties to healthcare and senior-living operators under long-term agreements, including primarily triple-net leases, under which tenants are typically responsible for property-level operating expenses, maintenance and taxes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.